Strattera, an attention deficit hyperactivity disorder drug, may increase suicidal thinking in children and adolescents, the Food and Drug Administration warned on Thursday.
“Children and adolescents being treated with Strattera should be closely monitored for clinical worsening, as well as agitation, irritability, suicidal thinking or behaviors, and unusual changes in behavior, especially during the initial few […]